Recently, it has been shown that promoter mutations in telomerase reverse transcriptase (TERT) gene are associated with a poor prognosis in thyroid cancer, especially with concurrent BRAFV600E mutation [9]. The gene discussed is TERT; the disease is thyroid gland carcinoma.